Search results
From Hype To Reality, AI Reshapes Pharmaceutical Industry Across Drug Discovery To Marketing -...
Benzinga via AOL· 14 hours agoPharmaceutical companies have been at the forefront of artificial intelligence for quite some time....
Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Looks Like They Deserve Their Pay Packet
Simply Wall St. via Yahoo Finance· 1 day agoIf non-salary compensation dominates total pay, it's an indicator that the executive...Compensation...
Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024 - WTOP News
WTOP Washington· 15 hours agoNEW YORK (AP) — Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen Inc., up $8 to $31.56. The salad restaurant chain beat analysts' first-quarter revenue forecasts.
Earnings call: Cipher Pharmaceuticals reports strong Q1 with revenue up 20% By Investing.com
Investing.com· 18 hours agoCipher Pharmaceuticals (OTC:CPHRF) Inc. (TSX:CPH) has released its Q1 2024 financial results,...
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 2 days agoTeva Pharmaceutical Industries Limited (NYSE:TEVA) Q1 2024 Earnings Call Transcript May 8, 2024 Teva...
Teva Pharmaceutical Industries Posts Narrower Loss In Q1 - Update
RTT News· 3 days agoTeva Pharmaceutical Industries Ltd. (TEVA) posted a first quarter net loss attributable to Teva of $139 million or $0.12 per share, compared to a net loss of $220 million ...
Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 4 days agoMexico's pharmaceutical and personal care industry is undergoing significant changes with the strategic moves announced by Genomma Lab International, S.A.B ...
NRx Pharmaceuticals eyes first commercial revenue in 2024, announces breakthroughs in bi-annual...
Invezz· 3 days agoNRx Pharmaceuticals, Inc. (Nasdaq: NRXP) is a clinical-stage biopharmaceutical company developing...
Teva stock gains on trial win, Q1 beat (NYSE:TEVA)
Seeking Alpha· 3 days agoTeva Pharmaceutical (TEVA) stock posts record gains due to better-than-expected Q1 revenue and positive Phase 3 trial results for its schizophrenia drug....
A Shocking Number of Doctors Don’t Understand Menopause
Bloomberg· 24 hours agoWomen deserve better health care at midlife, including more accurate information about hormone...